Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
26.40
+0.18 (0.69%)
Nov 21, 2024, 4:00 PM EST - Market closed
Royalty Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Market Capitalization | 15,554 | 12,497 | 17,432 | 17,116 | 19,426 | - | Upgrade
|
Market Cap Growth | 4.05% | -28.31% | 1.85% | -11.89% | - | - | Upgrade
|
Enterprise Value | 21,727 | 21,132 | 27,333 | 26,687 | 28,409 | - | Upgrade
|
Last Close Price | 26.40 | 27.24 | 37.36 | 37.00 | 45.72 | - | Upgrade
|
PE Ratio | 10.34 | 10.75 | 382.03 | 24.83 | 34.67 | - | Upgrade
|
Forward PE | 6.33 | 7.47 | 10.32 | 13.00 | 19.16 | - | Upgrade
|
PS Ratio | 5.22 | 5.31 | 7.79 | 7.48 | 9.15 | - | Upgrade
|
PB Ratio | 1.71 | 1.24 | 1.83 | 1.67 | 1.96 | - | Upgrade
|
P/TBV Ratio | 1.85 | 1.92 | 3.11 | 2.97 | 4.06 | - | Upgrade
|
P/FCF Ratio | 5.56 | 4.18 | 8.13 | 8.48 | 9.55 | - | Upgrade
|
P/OCF Ratio | 5.56 | 4.18 | 8.13 | 8.48 | 9.55 | - | Upgrade
|
PEG Ratio | 1.60 | 2.65 | 0.94 | 1.12 | 1.97 | - | Upgrade
|
EV/Sales Ratio | 9.59 | 8.98 | 12.22 | 11.66 | 13.39 | - | Upgrade
|
EV/EBITDA Ratio | - | 14.11 | 29.44 | 18.36 | 16.87 | - | Upgrade
|
EV/EBIT Ratio | 14.07 | 14.16 | 29.62 | 18.65 | 17.11 | - | Upgrade
|
EV/FCF Ratio | 7.76 | 7.07 | 12.75 | 13.23 | 13.96 | - | Upgrade
|
Debt / Equity Ratio | 0.74 | 0.61 | 0.75 | 0.69 | 0.59 | 1.02 | Upgrade
|
Debt / EBITDA Ratio | - | 4.10 | 7.66 | 4.88 | 3.46 | 2.37 | Upgrade
|
Debt / FCF Ratio | 2.72 | 2.05 | 3.32 | 3.52 | 2.86 | 3.76 | Upgrade
|
Asset Turnover | 0.13 | 0.14 | 0.13 | 0.14 | 0.15 | 0.15 | Upgrade
|
Quick Ratio | 1.53 | 7.87 | 2.11 | 16.77 | 8.73 | 2.50 | Upgrade
|
Current Ratio | 1.54 | 7.90 | 2.19 | 16.81 | 8.76 | 2.50 | Upgrade
|
Return on Equity (ROE) | 17.28% | 17.34% | 2.33% | 12.32% | 21.23% | 46.04% | Upgrade
|
Return on Assets (ROA) | 5.69% | 5.62% | 3.36% | 5.33% | 7.29% | 13.77% | Upgrade
|
Return on Capital (ROIC) | 5.75% | 5.68% | 3.39% | 5.41% | 7.38% | 13.97% | Upgrade
|
Earnings Yield | 7.36% | 9.08% | 0.25% | 3.62% | 5.02% | - | Upgrade
|
FCF Yield | 18.00% | 23.91% | 12.30% | 11.79% | 10.47% | - | Upgrade
|
Dividend Yield | 3.18% | 2.94% | 2.03% | 1.84% | 0.66% | - | Upgrade
|
Payout Ratio | 32.89% | 31.58% | 778.21% | 46.02% | 40.80% | 31.48% | Upgrade
|
Buyback Yield / Dilution | -33.46% | -37.66% | -5.59% | -10.48% | - | - | Upgrade
|
Total Shareholder Return | -30.28% | -34.72% | -3.55% | -8.64% | 0.66% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.